Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Childhood Overweight, Obesity, and the Metabolic Syndrome in Developing Countries
2007
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
2010 Standout
The metabolic syndrome
2010 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology
2004 Standout
Exercise Standards for Testing and Training
2013 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
The Role of Stress Echocardiography in Valvular Heart Disease: A Current Appraisal
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Global Epidemic of the Metabolic Syndrome
2018 Standout
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors
1999
Non-alcoholic fatty liver disease
2021 Standout
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease
2003 Standout
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial
2002
High–monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations
1999 Standout
Arterial stiffness and the systolic hypertension syndrome
2004
Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
2019
Burden of valvular heart diseases: a population-based study
2006 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Mitral Annulus Velocity in the Evaluation of Left Ventricular Diastolic Function in Atrial Fibrillation
1999
Contamination of Botanical Dietary Supplements byDigitalis lanata
1998
Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008
2013
Herbal Medicines and Perioperative Care
2001 Standout
Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second‐generation antipsychotics
2008
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
2009 Standout
Epidemiology of Heart Failure
2020
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS‐CoV‐2 ‘long‐haulers’?
2020
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East
2009
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Late Results of Percutaneous Mitral Commissurotomy up to 20 Years
2012
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Pathophysiology of Sleep Apnea
2010 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
The Metabolic Syndrome
2008 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006
2010
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Works of Ömer Kozan being referenced
Prevalence of the metabolic syndrome among Turkish adults
2006
Contribution of mitral valve reserve capacity to sustained symptomatic improvement after balloon valvutomy in mitral stenosis: Implications for restenosis for restenosis
1993
Effect of Nonalcoholic Fatty Liver Disease on In-Hospital and Long-Term Outcomes in Patients With ST–Segment Elevation Myocardial Infarction
2017
Urginea Maritima(Squill) Toxicity
1995
Use of Intraventricular Dispersion of the Peak Diastolic Flow Velocity as a Marker of Left Ventricular Diastolic Dysfunction in Patients with Atrial Fibrillation
1998
Heart fAilure Prevalence and Predictors in TurkeY (HAPPY) Çalışması
2012
Correlation between serum lipoprotein (a) and angiographic coronary artery disease in non‐insulin‐dependent diabetes mellitus
1997
The Effects of Nisoldipine on Carotid Artery Stiffness and Left Ventricular Functions.
1995
Comparison of Angiographic and Clinical Outcome After Cutting Balloon and Conventional Balloon Angioplasty in Vessels Smaller than 3 mm in Diameter: A Randomized Trial.
1998
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction
2016